Sun Pharma Announces USFDA Tentative Approval For Generic Rilutek(R)

Links shared publicly online about this topic.

836
total visits

Sun Pharma Announces USFDA Tentative Approval For Generic Rilutek(R)

Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE:SUNPHARMA, BSE: 524715) announced that USFDA has granted a tentative approval for its Abbreviated New Drug Application

View full resource at medicalnewstoday.com

Tags: Drug, Pharma

Most Recently Shared on September 30, 2010 at 3:05 pm By:

MNT Drug Approvals

Sun Pharma Announces USFDA Tentative Approval For Generic Rilutek(R) http://mnt.to/3Kyz #regulatory

2 years ago...

Retweet

Favorite

Also Shared By:

MNT - Muscular Dys

USFDA grants Sun Pharma tentative approval for generic Stalevo ANDA

news-medical.net — “Sun Pharmaceutical Industries Ltd. announced that USFDA has granted its subsidiary a tentative approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Orion's Stalevo® tablets.” View full resource at news-medical.net

Most Recently Shared on October 1, 2010 at 9:10 pm By:

News-Medical.Net Health News

Parkinson's Disease: USFDA grants Sun Pharma tentative approval for generic Stalevo ANDA: Sun Pharmaceutical Indus... http://bit.ly/9yLRas

2 years ago...

Retweet

Favorite

Sun Pharma Announces USFDA Tentative Approval For Generic Namenda(R) Tablets

medicalnewstoday.com — “Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE:SUNPHARMA, BSE: 524715) announced that USFDA has granted its subsidiary a tentative approval for its Abbreviated New Dr” View full resource at medicalnewstoday.com